OdySight® Terms of Use

V.3.2/ 2022-10-11
For the use of the application OdySight® of Tilak Healthcare SAS ("Tilak Healthcare")
with place of business at 74 rue du Faubourg Saint Antoine, 75012 Paris, France
Paris Chamber of Commerce B 820 343 044
In certain countries, Tilak Healthcare has entered into agreements with professional corporations to promote OdySight; any such professional corporation shall be referred to as Tilak Healthcare's "Co-promoter".
email: contact@tilakhealthcare.com

Last updated: October 1st, 2022.

PLEASE READ THESE TERMS CAREFULLY BEFORE USING ODYSIGHT® APPLICATION

By downloading and using this Application (including its limited use version), you are agreeing to these OdySight® Terms of Use.

OdySight® application (“Application”) means the OdySight® mobile device application, a medical device made available to you (“you” or “User”) by Tilak Healthcare on prescription by your healthcare professional and providing you with a wide array of services including, without limitation, the access to the Application, self-testing to allow a remote monitoring on visual parameters, collection and transfer of test results and decreases in visual acuity to your healthcare professional’s dashboard (collectively, the "Services").

In anticipation of your prescription of the Application by a healthcare professional, you can access the limited version of OdySight® to perform certain self-testing on visual parameters. Such access is limited to your use of OdySight pending healthcare professional decision to confirm the access to the Application or decline based on their own decision. For the avoidance of doubt, no collection or transfer of test results will be made by Tilak Healthcare to your healthcare professional. The access to the limited version of OdySight is limited to a maximum of ten (10) calendar days. Upon expiration of this period of time or healthcare professional’s decision not to prescribe the Application, your access to the limited version of OdySight will be terminated without any additional notice, indemnity or compensation of any kind.

For simplicity, references to the terms Application and Services (to the exception of transfer and analysis of data and decreases in visual acuity collected by the Application) in the rest of these Terms of Use shall be deemed to include the limited version of OdySight® and the related limited services.

The Application is made available free of charge for the sole use by the User only on User’s smart device -tablet or smartphone (each a “Device”) once connected to internet, provided that the Device shall meet the minimal technical characteristics to allow the functioning of the Application, available with the list of compatible Devices on https://odysight.app/faq-us/supported-devices-list.

PLEASE NOTE THAT THE APPLICATION IS NOT ADAPTED TO
  • THE USER WITH A BINOCULAR VISUAL ACUITY WITH HABITUAL CORRECTION OF LESS THAN 3/10 (0.5 LOGMAR; 20/63), OR
  • EPILEPTIC USERS.

Tilak Healthcare™ and OdySight® are trademarks of Tilak Healthcare.
AppStore® is a trademark of Apple Inc.
iOS® is a trademark of Cisco Inc.
74 rue du Faubourg Saint Antoine 75012 Paris, France
+ 33 (0) 762271842
Copyright © 2020 Tilak Healthcare S.A.S All rights reserved.
Date of the last update of the site: August 19, 2021